Short Interest in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Increases By 30.5%

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) was the recipient of a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 997,700 shares, a growth of 30.5% from the August 31st total of 764,600 shares. Based on an average daily trading volume, of 328,600 shares, the short-interest ratio is presently 3.0 days. Approximately 1.8% of the shares of the company are short sold.

Aveanna Healthcare Price Performance

Shares of NASDAQ:AVAH traded down $0.16 on Friday, hitting $5.17. The company’s stock had a trading volume of 330,571 shares, compared to its average volume of 177,866. Aveanna Healthcare has a 1 year low of $0.85 and a 1 year high of $5.95. The company has a market capitalization of $999.00 million, a PE ratio of -8.62 and a beta of 2.13. The company has a 50-day simple moving average of $4.96 and a 200 day simple moving average of $3.41.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings data on Thursday, August 8th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. The firm had revenue of $504.96 million during the quarter, compared to analysts’ expectations of $494.02 million. On average, equities research analysts expect that Aveanna Healthcare will post -0.09 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

AVAH has been the topic of a number of recent research reports. UBS Group upped their price target on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the company a “sell” rating in a research note on Friday, August 9th. Deutsche Bank Aktiengesellschaft raised their price target on Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “buy” rating in a report on Friday, August 9th. Finally, Royal Bank of Canada boosted their price objective on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “sector perform” rating in a research note on Friday, August 9th.

Institutional Investors Weigh In On Aveanna Healthcare

A number of institutional investors have recently made changes to their positions in AVAH. Nut Tree Capital Management LP boosted its position in Aveanna Healthcare by 11.7% during the fourth quarter. Nut Tree Capital Management LP now owns 12,372,649 shares of the company’s stock valued at $33,159,000 after buying an additional 1,296,045 shares during the period. King Street Capital Management L.P. grew its position in Aveanna Healthcare by 50.6% during the 4th quarter. King Street Capital Management L.P. now owns 6,400,000 shares of the company’s stock worth $17,152,000 after acquiring an additional 2,150,000 shares during the last quarter. Acadian Asset Management LLC increased its stake in Aveanna Healthcare by 185.6% in the 1st quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock worth $72,000 after purchasing an additional 19,096 shares during the period. Vanguard Group Inc. lifted its position in Aveanna Healthcare by 1.8% in the first quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock valued at $6,402,000 after purchasing an additional 44,970 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in shares of Aveanna Healthcare by 6.6% during the second quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock valued at $413,000 after purchasing an additional 9,243 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.